比较实验室检查、超声或磁共振弹性成像检测非酒精性脂肪性肝病患者纤维化的荟萃分析
该系统性综述与荟萃分析纳入64篇文章共13046例非酒精性脂肪性肝病(NAFLD)受试者,比较APRI、FIB-4、BARD评分、NAFLD纤维化评分(NFS)、FibroScan、剪切波弹性成像(SWE)和磁共振弹性成像(MRE)诊断肝纤维化的效能。结果显示MRE和SWE对纤维化分期的诊断准确性可能最高;在四种无创简单指数中,NFS和FIB-4对检测进展性纤维化可能提供最佳诊断性能。
要点
- MRE和SWE对NAFLD患者纤维化分期的诊断准确性可能最高。
- 四种无创简单指数中,NFS和FIB-4对检测进展性纤维化可能提供最佳诊断性能。
- NAFLD患者中进展性纤维化的总体平均患病率为24.0%。
核心结论
- MRE和SWE对NAFLD患者纤维化分期的诊断准确性可能最高。
- 在四种无创简单指数中,NFS和FIB-4对检测进展性纤维化可能提供最佳诊断性能。
研究设计与样本
- 该系统综述与荟萃分析纳入64篇文章,共13046例NAFLD受试者。
- 比较APRI、FIB-4、BARD评分、NFS、FibroScan、SWE和MRE诊断NAFLD患者肝纤维化的效能。
- 采用荟萃回归探索异质性。
主要发现
- NAFLD患者中显著性纤维化、进展性纤维化和肝硬化的总体平均患病率分别为45.0%、24.0%和9.4%。
- APRI阈值1.0和1.5检测进展性纤维化的敏感性和特异性分别为50.0%和84.0%以及18.3%和96.1%。
- FIB-4阈值2.67和3.25检测进展性纤维化的敏感性和特异性分别为26.6%和96.5%以及31.8%和96.0%。
- BARD评分(阈值2)、NFS(阈值-1.455)、FibroScan M(阈值8.7-9)、SWE和MRE检测进展性纤维化的汇总敏感性和特异性分别为0.76和0.61、0.72和0.70、0.87和0.79、0.90和0.93以及0.84和0.90。
- APRI、FIB-4、BARD评分、NFS、FibroScan M探头、XL探头、SWE和MRE诊断进展性纤维化的汇总AUROC值分别为0.77、0.84、0.76、0.84、0.88、0.85、0.95和0.96。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Many noninvasive methods for diagnosing liver fibrosis (LF) have been proposed. To determine the best method for diagnosing LF in nonalcoholic fatty liver disease (NAFLD), we conducted a systemic review and meta-analysis to compare the performance of aspartate aminotransferase to platelets ratio index (APRI), fibrosis-4 index (FIB-4), BARD score, NAFLD fibrosis score (NFS), FibroScan, shear wave elastography (SWE), and magnetic resonance elastography (MRE) for diagnosing LF in NAFLD. We compared the sensitivity, specificity, positive predictive value, negative predictive value, and area under the receiver operating characteristic curve (AUROC) of these noninvasive methods for detecting significant fibrosis (SF), advanced fibrosis (AF), and cirrhosis. Heterogeneity was explored using meta-regression. Sixty-four articles with a total of 13,046 NAFLD subjects were included. The overall mean prevalence of SF, AF, and cirrhosis was 45.0%, 24.0%, and 9.4% in NAFLD patients, respectively. With an APRI threshold of 1.0 and 1.5, the sensitivities and specificities were 50.0% and 84.0% and 18.3% and 96.1%, respectively, for AF. With a FIB-4 threshold of 2.67 and 3.25, the sensitivities and specificities were 26.6% and 96.5% and 31.8% and 96.0%, respectively, for AF. The summary sensitivities and specificities of BARD score (threshold of 2), NFS (threshold of -1.455), FibroScan M (threshold of 8.7-9), SWE, and MRE for detecting AF were 0.76 and 0.61, 0.72 and 0.70, 0.87 and 0.79, 0.90 and 0.93, and 0.84 and 0.90, respectively. The summary AUROC values using APRI, FIB-4, BARD score, NFS, FibroScan M probe, XL probe, SWE, and MRE for diagnosing AF were 0.77, 0.84, 0.76, 0.84, 0.88, 0.85, 0.95, and 0.96, respectively. CONCLUSION: MRE and SWE may have the highest diagnostic accuracy for staging fibrosis in NAFLD patients. Among the four noninvasive simple indexes, NFS and FIB-4 probably offer the best diagnostic performance for detecting AF. (Hepatology 2017;66:1486-1501).
引用
- Xiao G, Zhu S, Xiao X, et al. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis. Hepatology. 2017. PMID: 28586172. doi:10.1002/hep.29302
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。